About: Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
Sector: Consumer Defensive
Industry: Household & Personal Products
Latest price: $17.59 (+1.15%)
KVUE NYSE Kenvue Inc.
Kenvue Inc. share price
KVUE price activity
Último preço
$ 17,590
Variação (24h)
0,20 USD (1,15%)
Volume
10.86M
Volume (média 4 sem.)
-
Abertura
$ 17,46
Variação do dia
$ 17,41 - $ 17,65
Fechamento anterior
$ 17,39
Último negócio
06 Oct, 8:09 pm GMT+0
Atrasado
06 Oct, 8:09 pm GMT+0
KVUE price performance
Atrasado
06 Oct, 8:09 pm GMT+0
quote.marketSignals